Abstract
VP.56a Real-world assessment of onasemnogene abeparvovec treatment in patients with spinal muscular atrophy: RESTORE/post-marketing surveillance in Japan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have